ILMN News and Press, Illumina Inc. From 01/08/26

Illumina Appoints Dr. Eric Green as Chief Medical Officer PR Newswire Veteran genomics leader joins Illumina to advance global medical strategy Illumina chief commercial officer to depart for role as a life science tools company CEO  SAN DIEGO , Jan. 8, 2026 /PRNew...

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis PR Newswire Integrated software, AI-driven analytics, and frictionless workflows enable customers to harness the full power of biological insights SAN DIEGO , Jan. 6, 2026 /PRNew...

2026-01-05 10:05:37 ET Vijay Kumar from Evercore ISI issued a price target of $155.00 for ILMN on 2026-01-05 14:50:48. The adjusted price target was set to $155.00. At the time of the announcement, ILMN was trading at $138.4997. The overall price target consensus is at $...

2025-12-28 09:02:58 ET Shares of life sciences instrument concern Standard BioTools Inc. ( LAB ) have rallied some 20% since its 3Q25 financial report on November 4, 2025, while it awaits the close of its SomaScan sale in 1H26. The prime reason for the rally has been buying from...

2025-12-18 11:20:17 ET Although the shares of long-read sequencing specialist Pacific Biosciences of California, Inc. ( PACB ) (“PacBio”) have done better of late, rising more than 25% since my last "Buy" update in February and outperforming both Illumina ( ILMN ) ...

2025-12-15 06:06:15 ET from Barclays issued a price target of $110.00 for ILMN on 2025-12-15 10:55:04. The adjusted price target was set to $110.00. At the time of the announcement, ILMN was trading at $134.85. The overall price target consensus is at $115.25 with high p...

/C O R R E C T I O N -- MyOme, Inc/ PR Newswire In the news release, Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually, issued Dec. 11 by MyOme, Inc over PR Newswire...

2025-12-14 14:00:20 ET ... Read the full article on Seeking Alpha For further details see: Healthcare Dashboard For December And Focus On PJP

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually PR Newswire Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses a...

2025-12-09 16:15:00 ET Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to b iotech ETFs, they give sector participants exposure to many biotech companies via one vehicle. ETFs are a popular choice as they allow ...